TABLE 3.
Characteristics of the KTRs group and the control group after matching
| Variables | KTRs group (N = 83) | Control group (N = 83) | p-value |
|---|---|---|---|
| Age (years), median (IQR) | 67.2 (58.5–74.1) | 65.1 (56.1–79.3) | .873 |
| Men, n (%) | 52 (82.6) | 55 (82.7) | .627 |
| BMI (kg/m2), median (IQR) | 26.6 (22.7–28.7) | 26.3 (22.6–29.4) | .982 |
| Coexisting conditions | |||
| Hypertension, n (%) | 68 (81.9) | 62 (74.7) | .258 |
| Cardiopathy, n (%) | .924 | ||
| None | 54 (65.1) | 50 (60.2) | |
| Coronary artery disease | 15 (18.1) | 16 (19.2) | |
| Valvular heart disease | 1 (1.2) | 2 (2.4) | |
| Dilated heart disease | 3 (3.6) | 5 (6.0) | |
| Other cardiopathy | 10 (12.0) | 10 (12.0) | |
| Atrial fibrillation, n (%) | 19 (22.9) | 16 (19.3) | |
| Diabetes Mellitus, n(%) | 41 (49.4) | 44 (53.0) | .641 |
| Chronic lung disease, n (%) | .952 | ||
| None | 73 (88.0) | 73 (88.0) | |
| Chronic obstructive pulmonary disease | 4 (4.8) | 4 (4.8) | |
| Asthma | 3 (3.6) | 4 (4.8) | |
| Bronchiectasis | 3 (3.6) | 2 (2.4) | |
| eGFRa, n (%) | .436 | ||
| eGFR <30 mL/min/1.73 m2 | 19 (22.9) | 21 (25.3) | |
| eGFR 30–60 mL/min/1.73 m2 | 42 (50.6) | 34 (41.1) | |
| eGFR >60 mL/min/1.73 m2 | 22 (26.5) | 28 (33.7) | |
| Follow-up (days), median (IQR) | 13 (9–21) | 9 (4–13) | .001 |
Abbreviations: BMI, body mass index; eGFR, estimated glomerular filtration rate; IQR, interquartile range; KTRs, kidney transplant recipients.
a
Determined with the MDRD equation.